Search Within

Christopher G Azzoli

  1. "2009"
Formats
  1. Meeting Abstract (6)
  2. Journal Article (1)
Groups
  1. Department of Medicine (7)
  2. Solid Tumor Oncology Division (7)
  3. Thoracic Oncology (7)
  4. Biostatistics Service (3)
  5. Body Imaging Service (3)
  6. Epidemiology and Biostatistics (3)

More Groups

People
  1. Mark Kris (7)
  2. Vincent Miller (6)
  3. Gregory Riely (5)
  4. Naiyer Rizvi (4)
  5. Michelle Ginsberg (3)
  6. Bernard Park (2)

More People

Years
  1. 2009 (7)
Publications
  1. Journal of Thoracic Oncology (4)
  2. Journal of Clinical Oncology (3)
Publishers
  1. Elsevier Inc. (4)
  2. American Society of Clinical Oncology (3)

Results (7)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase II study of induction and adjuvant bevacizumab in patients with stage IB-IIIA non-small cell lung cancer (NSCLC) receiving induction docetaxel and cisplatin
    Meeting Abstract

    Price, K.; Kris, M. G.; Rusch, V.; Finley, D. J.; Azzoli, C. G.; Downey, R. J.; Bains, M. S.; Miller, V. A.; Rizk, N.; Rizvi, N. A.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Impact on disease-free survival of adjuvant erlotinib or gefitinib in patients with resected lung adenocarcinomas that harbor epidermal growth factor receptor (EGFR) mutations
    Meeting Abstract

    Janjigian, Y. Y.; Park, B. J.; Kris, M. G.; Miller, V. A.; Riely, G. J.; Zheng, J.; Dycoco, J. P.; Shen, R.; Azzoli, C. G.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Reflex testing of lung adenocarcinomas for EGFR and KRAS mutations: The initial Memorial Sloan-Kettering Cancer Center (MSKCC) experience
    Meeting Abstract

    Zakowski, M. F.; Ladanyi, M.; Rekhtman, N.; Park, B.; Finley, D.; Azzoli, C.; Kris, M. G.; Rusch, V.; Miller, V.; Riely, G.
    Journal of Thoracic Oncology (2009)

    Fulltext@MSK | Save
  • Phase 1 trial of cetuximab and erlotinib in patients with lung adenocarcinoma and acquired resistance to erlotinib
    Meeting Abstract

    Riely, G. J.; Janjigian, Y. Y.; Pereira, L. K.; Azzoli, C. G.; Pietanza, M. C.; Krug, L. M.; Rizvi, N. A.; Kris, M. G.; Ginsberg, M. S.; Pao, W.; more...
    Journal of Thoracic Oncology (2009)

    Fulltext@MSK | Save
  • Phase II trial of dasatinib for patients demonstrating acquired resistance to treatment with the epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) erlotinib (E) or gefitinib (G)
    Meeting Abstract

    Johnson, M. L.; Riely, G. J.; Rizvi, N. A.; Azzoli, C. G.; Kris, M. G.; Ginsberg, M. S.; Pao, W.; Miller, V. A.
    Journal of Thoracic Oncology (2009)

    Fulltext@MSK | Save
  • A prospective study of serial measurements of cell-free DNA in plasma, radiographic response, and overall survival in patients with metastatic non-small cell lung cancer (NSCLC)
    Meeting Abstract

    Azzoli, C. G.; Johnson, M.; Morita, S.; Motoyama, K.; Subzwari, S.; Hsu, M.; Shen, R. L.; Danenberg, K.; Danenberg, P.; Kris, M. G.
    Journal of Thoracic Oncology (2009)

    Fulltext@MSK | Save
  • Randomized phase II study of pulse erlotinib before or after carboplatin and paclitaxel in current or former smokers with advanced non-small-cell lung cancer
    Journal Article

    Riely, G. J.; Rizvi, N. A.; Kris, M. G.; Milton, D. T.; Solit, D. B.; Rosen, N.; Senturk, E.; Azzoli, C. G.; Brahmer, J. R.; Sirotnak, F. M.; more...
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save